These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 10928461

  • 1. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 2. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J.
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [Abstract] [Full Text] [Related]

  • 3. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 4. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 5. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
    Kluft C.
    Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
    [No Abstract] [Full Text] [Related]

  • 6. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 7. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):373-81. PubMed ID: 12138364
    [Abstract] [Full Text] [Related]

  • 8. The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
    Bremme K, Hamad RR, Berg E, Strandberg K, Stenflo J.
    Thromb Res; 2012 Oct; 130(4):636-9. PubMed ID: 22154243
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 10. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 11. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J, Daly L, Carroll E.
    Int J Fertil; 1987 Dec 11; 32 Suppl():21-8. PubMed ID: 2906344
    [Abstract] [Full Text] [Related]

  • 12. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I, Gerö G, Demeter J, Gáti I.
    Arzneimittelforschung; 1985 Dec 11; 35(3):630-3. PubMed ID: 3158320
    [Abstract] [Full Text] [Related]

  • 13. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 11; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 14. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 15. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
    Fruzzetti F, De Negri F, Morale M, Ricci C, Ferrini L, Bersi C, Genazzani AR, Carmassi F.
    Eur J Contracept Reprod Health Care; 1999 Sep 10; 4(3):113-8. PubMed ID: 10574636
    [Abstract] [Full Text] [Related]

  • 16. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun 10; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 17. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC, Montes MB, Franceschini SA, Toloi MR.
    Int J Fertil Womens Med; 2001 Jun 10; 46(5):265-70. PubMed ID: 11720199
    [Abstract] [Full Text] [Related]

  • 18. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan 10; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 19. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Stone S.
    Int J Fertil Menopausal Stud; 1993 Jan 10; 38 Suppl 3():117-21. PubMed ID: 8260969
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
    Winkler UH, Daume E, Sudik R, Oberhoff C, Bier U, Hallmann C, Andreas JO, Schindler AE.
    Eur J Contracept Reprod Health Care; 1999 Sep 10; 4(3):145-54. PubMed ID: 10574640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.